Holen Sie sich die Stockscreener-App
3.20
0.62%
-0.02
Silo Pharma Inc Aktie (SILO) Neueste Nachrichten
Silo Pharma (SILO) trims cash burn, mitigates going-concern risk in Q2 2026 - stocktitan.net
Silo Pharma, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com
Silo Pharma (SILO) investor group discloses 9.99% warrant-based ownership cap - stocktitan.net
Silo Pharma receives European patent for SPC-15 PTSD treatment By Investing.com - Investing.com South Africa
Silo Pharma Announces European Patent Grant for SPC-15 PTSD Prevention Therapy - Quiver Quantitative
A nasal PTSD treatment is patented for use before extreme stress - stocktitan.net
Silo Pharma, Inc. SEC Filing (Aug 7, 2026) - stocktitan.net
Silo Pharma Subsidiary QwikAgents Collaborates with Amazon Web Services Premier Tier Partner Caylent to Advance Enterprise AI Platform - marketscreener.com
QwikAgents' planned AWS platform is expected to improve security and scale - stocktitan.net
Silo Pharma Inc (SILO) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
SILO|Silo Pharma Inc|Price:4.210|Chg%:+0.020 - TradingKey
Silo Pharma Inc (NASDAQ: SILO) Share Price, SILO Stock News, SILO Share Price & Updates - Kalkine
Silo Pharma, Inc. Revenue Breakdown – NASDAQ:SILO - tradingview.com
Silo Pharma Inc (SILO) Financial Health: Profitability & Balance Sheet Analysis - tradingkey.com
Silo Pharma Inc. Q4 2023 Earnings: Wider-Than-Expected Loss Weighs on SharesFull Year Guidance - dars.gov.et
Silo Pharma Inc (SILO) Income Statement - TradingKey
SILO|Silo Pharma Inc|Price:4.470|Chg%:+0.010 - TradingKey
Silo Pharma Inc (SILO) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Silo Pharma Inc (SILO) Valuation: PE, PB & Fair Value Analysis - TradingKey
TradingKey - TradingKey
Form S-3 Silo Pharma Inc For: 24 July - Investing.com India
Form S-3 Silo Pharma Inc For: 24 July By Investing.com - Investing.com South Africa
Silo Pharma Selling Shareholders Offer On Resale Basis 1.9 Million Shares Of Silo Pharma Common StockSEC Filing - TradingView
Silo Pharma Advances AI Agent Platform Toward Commercial Launch And Progresses Lead PTSD Drug Program SPC-15 - marketscreener.com
Silo Pharma plans AI platform launch, advances PTSD drug program By Investing.com - Investing.com Canada
Silo Pharma Advances QwikAgents Commercial Launch and SPC-15 Development - Quiver Quantitative
Silo Pharma expects its PTSD nasal-spray study to finish in 60 days - Stock Titan
Silo Pharma raises $4 million in private placement By Investing.com - Investing.com Nigeria
Silo Pharma, Inc. (SILO) Stock: Slide 4.92% as QwikAgents Joins AMD AI Developer Program - CoinCentral
Silo Pharma (SILO) Q4 2023 Earnings: EPS Misses by Wide Margin, No Revenue Reported; Stock Gains 1.89%Gross Profit Margin - po-news-eg.net
Silo Pharma unit eyes faster AI agent development through AMD partnership - MSN
Silo Pharma (SILO) completes $4,000,015 private exempt securities sale - Stock Titan
Silo Pharma Advances AI Integration and PTSD Treatment Development - sekbernews.id
Is Silo Pharma, Inc. (SILO) Stock an AI Opportunity After NVIDIA Partnership Boosts QwikAgents Platform? - Yahoo Finance
Silo Pharma Subsidiary QwikAgents Joins AMD AI Developer Program to Accelerate AI Agent Platform - citybuzz -
Silo Pharma (SILO) Shares Drop 4.92% Following QwikAgents' Entry into AMD AI Developer Program - Blockonomi
Why Is Silo Pharma Stock Volatile Today?SILO Pharma (NASDAQ:SILO) - Benzinga
Silo Pharma’s QwikAgents Joins AMD AI Developer Program to Advance AI Agent Platform - Yahoo Finance
Silo Pharma subsidiary joins AMD AI developer program By Investing.com - Investing.com Canada
Silo Pharma’s QwikAgents Accepted Into AMD AI Developer Program - Quiver Quantitative
Silo Pharma's QwikAgents Joins AMD AI Developer Program to Advance Enterprise AI Agent Platform - 富途牛牛
Silo Pharma Raises Approximately $3.5 Million Net in Private Placement; Grants Resale Rights - TradingView
SILO Q4 2023 Earnings: EPS Misses Estimates as Pre-Revenue Biotech Faces HeadwindsEBITDA Analysis - DonanımHaber
Number of shareholders of Silo Pharma, Inc. – NASDAQ:SILO - TradingView
Price to earnings forward of Silo Pharma, Inc. – NASDAQ:SILO - TradingView
Price to sales forward of Silo Pharma, Inc. – NASDAQ:SILO - TradingView
Enterprise value to EBIT forward of Silo Pharma, Inc. – NASDAQ:SILO - TradingView
CCC Intelligent Solutions, Circle rise premarket; Silo Pharma, Fermi America fall - Investing.com Canada
SILO: H.C. Wainwright & Co. Leads Exclusive Offering - GuruFocus
Silo Pharma (SILO) Stock Tumbles 28% Following $4M Financing Announcement - Blockonomi
Silo Pharma (SILO) Stock: Shares Plunge 28% After $4 Million Private Placement - CoinCentral
Silo Pharma Sinks on Stock Sale - Baystreet.ca
Silo Pharma Shares Slide After Announcing Up to $11.7 Million Private Placement (SILO) - Yahoo Finance
Silo Pharma Launches Private Placement to Raise Up to $11.7 Million - Moomoo
Silo Pharma raises $4 million in private placement - Investing.com
Silo Pharma stock tumbles 22% on dilutive private placement - Investing.com
0.52%
0.07%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):